C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction

Annals of Epidemiology

Volumn 13, Issue 3, 2003, Pages 170-177

  Witherell, Heidi L ^a   Smith, Karen L ^a   Friedman, Gary D ^a,b   Ley, Catherine ^a   Thom, David H ^a   Orentreich, Norman ^c   Vogelman, Joseph H ^c   Parsonnet, Julie ^a,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c Orentreich Foundation for the Advancement of Science Inc   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

C reactive Protein; Chlamydia pneumoniae; Cytomegalovirus; Helicobacter pylori; Myocardial Infarction; Prospective Study

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; COHORT ANALYSIS; CYTOMEGALOVIRUS; FOLLOW UP; HEART INFARCTION; HELICOBACTER PYLORI; HUMAN; MEDICAL EDUCATION; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SOCIAL STATUS; SOCIOECONOMICS;

ADULT; AGED; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERIOSCLEROSIS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; RISK FACTORS;

EID: 0037371132     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(02)00276-4     Document Type: Article

References (35)

1. Saikku P., Leinonen M., Tenkanen L., Linnanmaki E., Ekman M.R., Manninen V.et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 116:1992;273-278.
2. Thom D.H., Grayston J.T., Siscovick D.S., Wang S.P., Weiss N.S., Daling J.R. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA. 268:1992;68-72.
3. McDonald K., Rector T.S., Braulin E.A., Kubo S.H., Olivari M.T. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol. 64:1989;359-362.
4. Grattan M.T., Moreno-Cabral C.E., Starnes V.A., Oyer P.E., Stinson E.B., Shumway N.E. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 261:1989;3561-3566.
5. Skowronski E.W., Mendoza A., Smith S.C. Jr., Jaski B.E. Detection of cytomegalovirus in paraffin-embedded postmortem coronary artery specimens of heart transplant recipients by the polymerase chain reaction. implications of cytomegalovirus association with graft atherosclerosis J Heart Lung Transplant. 12:1993;717-723.
6. Zhou Y.F., Leon M.B., Waclawiw M.A., Popma J.J., Yu Z.X., Finkel T.et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 335:1996;624-630.
7. Danesh J., Youngman L., Clark S., Parish S., Peto R., Collins R. Helicobacter pylori infection and early onset myocardial infarction. case-control and sibling pairs study BMJ. 319:1999;1157-1162.
8. Mendall M.A., Goggin P.M., Molineaux N., Levy J., Toosy T., Strachan D.et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 71:1994;437-439.
9. Zhou Y.F., Shou M., Guetta E., Guzman R., Unger E.F., Yu Z.X.et al. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation. 100:1999;1569-1575.
10. Lemstrom K.B., Aho P.T., Bruggeman C.A., Hayry P.J. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis. Arterioscler Thromb. 14:1994;2043-2052.
11. Laitinen K., Laurila A., Pyhala L., Leinonen M., Saikku P. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun. 65:1997;4832-4835.
12. Moazed T.C., Kuo C., Grayston J.T., Campbell L.A. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis. 175:1997;883-890.
13. Muhlestein J.B., Anderson J.L., Hammond E.H., Zhao L., Trehan S., Schwobe E.P.et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 97:1998;633-636.
14. Gupta S., Leatham E.W., Carrington D., Mendall M.A., Kaski J.C., Camm A.J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 96:1997;404-407.
15. Valantine H.A., Gao S.Z., Menon S.G., Renlund D.G., Hunt S.A., Oyer P.et al. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis. a post hoc analysis of a randomized, placebo-controlled study Circulation. 100:1999;61-66.
16. Lemstrom K.B., Bruning J.H., Bruggeman C.A., Koskinen P.K., Aho P.T., Yilmaz S.et al. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat. Circulation. 90:1994;1969-1978.
17. Pellicano R., Mladenova I., Broutet N., Salmi L.R., Megraud F. Is there an association between Helicobacter pylori infection and coronary heart disease? Eur J Epidemiol. 15:1999;611-619.
18. Danesh J. Is there a link between chronic Helicobacter pylori infection and coronary heart disease? Eur J Surg Suppl. 582:1998;27-31.
19. Zhu J., Quyyumi A.A., Muhlestein J.B., Nieto F.J., Horne B.D., Zalles-Ganley A.et al. Lack of Association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death. Am J Cardiol. 89:2002;155-158.
20. Ridker P.M., Danesh J., Youngman L., Collins R., Stampfer M.J., Peto R.et al. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infaraction among socioeconomically similar US men. Ann Intern Med. 135:2001;184-188.
21. Tracy R.P., Psaty B.M., Macy E., Bovill E.G., Cushman M., Cornell E.S.et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 17:1997;2167-2176.
22. Morrow D.A., Ridker P.M. C-reactive protein, inflammation, and coronary risk. Med Clin North Am. 84:2000;149-161.
23. Roivainen M., Viik-Kajander M., Palosuo T., Toivanen P., Leinonen M., Saikku P.et al. Infections, inflammation and the risk of coronary heart disease. Circulation. 101:2000;252-257.
24. Siscovick D.S., Schwartz S.M., Corey L., Grayston J.T., Ashley R., Wang S.P.et al. Chlamydia pneuominae, Herpes Simplex Virus Type 1, and Cytomegalovirus and Incident Myocardial Infarction and Coronary Heart Disease Death in Older Adults. Circulation. 102:2000;2335-2340.
25. Friedman G.D., Klatsky A.L., Siegelaub A.B., McCarthy N. Kaiser-Permanente epidemiologic study of myocardial infarction. Study design and results for standard risk factors. Am J Epidemiol. 99:1974;101-116.
26. Friedman G.D., Blaner W.S., Goodman D.S., Vogelman J.H., Brind J.L., Hoover R. Serum retinol and retinol-binding protein levels do not predict subsequent lung cancer. Am J Epidemiol. 123:1986;781-789.
27. Leinonen M., Linnanmaki E., Mattila K., Nieminin M.S., Valtonen V., Leirisalo-Repo M.et al. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog. 9:1990;67-73.
28. Lopes-Virella M.F., Virella G. Immunological and microbiological factors in the pathogenesis of atherosclerosis. Clin Immunol Immunopathol. 37:1985;377-386.
29. Tannenbaum S.H., Finko R., Cines D.B. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol. 137:1986;1532-1537.
30. Replogle M.L., Glaser S.L., Hiatt R.A., Parsonnet J. Biological sex as a risk factor for Helicobacter pylori infection in healthy young adults. Am J Epidemiol. 142:1995;856-863.
31. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger W.H. Jr. et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 106:1999;506-512.
32. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979. [published erratum appears in N Engl J Med 1997 Jul 31;337(5):356].
33. Ridker P.M., Hennekens C.H., Buring J.E., Kundsin R., Shih J. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med. 131:1999;573-577.
34. Hu H., Pierce G.N., Zhong G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest. 103:1999;747-753.
35. Anderson J.L., Muhlestein J.B., Carlquist J., Allen A., Trehan S., Nielson C.et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study Circulation. 99:1999;1540-1547.